𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil

✍ Scribed by Yathirajan, Hemmige S. ;Nagaraj, Basavegowda ;Gaonkar, Santhosh L. ;Narasegowda, Rajenahally S. ;Nagaraja, Padmarajaiah ;Bolte, Michael

Publisher
International Union of Crystallography
Year
2004
Tongue
English
Weight
200 KB
Volume
60
Category
Article
ISSN
1600-5368

No coin nor oath required. For personal study only.

✦ Synopsis

The title compound, morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-2-benzofuran-5-yl)-4methylhex-4-enoate, C 23 H 31 NO 7 , belongs to the group of immunosuppresant drugs. Its crystal structure is stabilized by OÐHÁ Á ÁO and CÐHÁ Á ÁO hydrogen bonds.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req